Clinical Study
Maternal Thyroid Dysfunction and Neonatal Thyroid Problems
Table 2
Neonatal thyroid disfunction in the study group.
| Patient no. | Group | Gestational age (week) | Maternal TSH level (mIU/mL)* | Maternal FT4 level (mIU/mL)* | Treatment of the mother | TSH level (mIU/mL) 1st week | FT4 level (ng/dL) 1st week | TSH level (mIU/mL) 3rd week | FT4 levels (ng/dL) 3rd week | TSH level (mIU/mL) 8th week | FT4 levels (ng/dL) 8th week | Diagnosis | Treatment |
| 1 | I | 38 | 5.6 | 1.1 | L-thyroxine | 6.3 | 1.55 | 7.44 | 1.2 | 1.4 | 1.3 | Transient hyperthyrotropinemia | (−) | 2 | I | 36 | 5.7 | 1.7 | L-thyroxine | 10.7 | 1.2 | 14.4 | 1.06 | 4.2 | 1.5 | Transient compensated hypothyroidism | (+) | 3 | II | 40 | 7.2 | 1.7 | L-thyroxine | 30.7 | 1.9 | 12.4 | 2.2 | 3.2 | 1.7 | Transient hyperthyrotropinemia | (−) | 4 | II | 34 | 0.9 | 1.6 | L-thyroxine | 21.8 | 2.7 | 3.3 | 1.4 | — | — | Transient hyperthyrotropinemia | (−) | 5 | II | 36 | 1.6 | 0.8 | L-thyroxine | 21.7 | 1.9 | 4.4 | 1.6 | — | — | Transient hyperthyrotropinemia | (−) | 6 | II | 38 | 5.3 | 1.2 | L-thyroxine | 29.7 | 2.2 | 9.9 | 1.6 | 5.8 | 1.2 | Transient hyperthyrotropinemia | (−) | 7 | II | 37 | 3.2 | 0.7 | L-thyroxine | 20.9 | 2.1 | 5.2 | 1.3 | — | — | Transient hyperthyrotropinemia | (−) |
|
|
If TSH > 7 mIU/mL, at the third week, TSH level is rechecked every two weeks until it comes down to normal values.
|